Your browser doesn't support javascript.
loading
Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen.
Sharabi, Andrew B; Nirschl, Christopher J; Kochel, Christina M; Nirschl, Thomas R; Francica, Brian J; Velarde, Esteban; Deweese, Theodore L; Drake, Charles G.
Afiliação
  • Sharabi AB; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland. Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Nirschl CJ; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Kochel CM; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Nirschl TR; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Francica BJ; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Velarde E; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Deweese TL; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland. Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. The Brady Urological Institute, Johns Hopkins University School of Medicine,
  • Drake CG; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland. Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Cancer Immunol Res ; 3(4): 345-55, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25527358
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Radiocirurgia / Apresentação Cruzada / Receptor de Morte Celular Programada 1 / Imunoterapia / Neoplasias Mamárias Experimentais / Antígenos de Neoplasias Tipo de estudo: Evaluation_studies Limite: Animals Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Radiocirurgia / Apresentação Cruzada / Receptor de Morte Celular Programada 1 / Imunoterapia / Neoplasias Mamárias Experimentais / Antígenos de Neoplasias Tipo de estudo: Evaluation_studies Limite: Animals Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2015 Tipo de documento: Article